Thyroid Nodules in Children and Cancer Risk

2016 ◽  
pp. 335-346
Author(s):  
Andrew J. Bauer
Keyword(s):  
2021 ◽  
Author(s):  
Taha Ulutan Kars ◽  
Mustafa Kulaksizoglu ◽  
İbrahim Kılınç

Objective: Thyroid cancer can be detected in 5–10% of patients with thyroid nodules. Management may be a challenge if fine-needle aspiration biopsy yields Bethesda III findings. Most of these cases undergo surgery and are ultimately found benign. Our aim was to evaluate whether serum osteopontin can accurately estimate thyroid cancer risk in cases with cytologically Bethesda III thyroid nodules and, thereby, decrease the number of unnecessary surgical interventions. Design and Methods: We obtained blood samples of cases with repeated cytologically Bethesda III thyroid nodules before surgery, and followed up the pathology results after thyroidectomy. We evaluated serum osteopontin from 36 patients with papillary thyroid cancer and compared them with 40 benign cases. Results: Serum osteopontin levels in patients with papillary thyroid cancer are significantly higher than in benign cases (mean serum osteopontin: 10.48 ± 3.51 ng/mL vs 6.14 ± 2.29 ng/mL, p<0.001). The area under the receiver operating characteristics curve was 0.851, suggesting that serum osteopontin could have considerable discriminative performance. Conclusions: In our preliminary study, high serum osteopontin levels can predict the risk of papillary thyroid cancer in thyroid nodules with Bethesda III cytology. Further studies are necessary to confirm these findings.


Thyroid ◽  
2018 ◽  
Vol 28 (8) ◽  
pp. 1004-1012 ◽  
Author(s):  
Pablo Valderrabano ◽  
Melissa J. McGettigan ◽  
Cesar A. Lam ◽  
Laila Khazai ◽  
Zachary J. Thompson ◽  
...  

2018 ◽  
Vol 64 (03/2018) ◽  
Author(s):  
Chenlu Zhu ◽  
Shuxiang Li ◽  
Xin Gao ◽  
Gengchao Zhu ◽  
Miaoli Song ◽  
...  

Thyroid ◽  
2018 ◽  
Vol 28 (2) ◽  
pp. 210-219 ◽  
Author(s):  
Pablo Valderrabano ◽  
Laila Khazai ◽  
Zachary J. Thompson ◽  
Susan C. Sharpe ◽  
Valentina D. Tarasova ◽  
...  

2008 ◽  
Vol 93 (11) ◽  
pp. 4175-4182 ◽  
Author(s):  
Erik K. Alexander

Background: Fine-needle aspiration remains the primary diagnostic intervention for the evaluation of most thyroid nodules larger than 1–1.5 cm. Although most aspirates provide diagnostic cytology, approximately 15–25% will be classified indeterminate (often referred to as follicular neoplasm, suspicious for carcinoma, or atypical). In such cases, abnormal cellular findings preclude interpretation of benignity, although only a minority will prove cancerous upon final histopathology. Nonetheless, patients with indeterminate aspirates are commonly referred for consideration of hemi- or near-total thyroidectomy. Recently, improved understanding and novel investigation of clinical, radiological, cytological, and molecular factors has allowed improved stratification of cancer risk. Conclusion: Although surgery continues to be commonly recommended, strategies for such patients should increasingly seek to define treatment based on the estimation of an individual’s thyroid cancer risk in comparison with associated operative risk and morbidity. In doing so, the rate of unnecessary surgical procedures and associated complications can be reduced.


Cureus ◽  
2018 ◽  
Author(s):  
Emilija Todorovic ◽  
Brandon S Sheffield ◽  
Steve Kalloger ◽  
Blair Walker ◽  
Sam M Wiseman

1992 ◽  
Vol 93 (4) ◽  
pp. 363-369 ◽  
Author(s):  
Antonino Belfiore ◽  
Giacomo Lucio La Rosa ◽  
Gianfranco Antonio La Porta ◽  
Dario Giuffrida ◽  
Giovanni Milazzo ◽  
...  

2010 ◽  
pp. P1-555-P1-555
Author(s):  
KH Baek ◽  
ES Kim ◽  
DJ Lim ◽  
MI Kang ◽  
KW Lee

Sign in / Sign up

Export Citation Format

Share Document